title: HIV+ MALT lymphoma remission induced by highly active antiretroviral therapy alone.
abstract: MALT lymphoma is usually described in association with Helicobacter pylori, HCV, HHV8, Campylobacter jejuni or in a setting of overreactive immunity. In HIV(+) patients, MALT lymphoma is most commonly described in children. We describe here an original case of HIV(+) MALT lymphoma with bronchial, conjuctival and laryngeal involvement for which a clinical and histopathological remission has been obtained with HAART alone. We conclude that HIV, as well as H. pylori, C. jejuni and HCV can target lymphogenesis in MALT lymphoma.
authors.affiliation: Service de Mèdecine Interne, Hôpital Béclère, Clamart, France. thomas.girard@cch.ap-hop-paris.fr
authors.forename: Thomas
authors.initials: T
authors.lastname: Girard
authors.forename: Isabelle
authors.initials: I
authors.lastname: Luquet-Besson
authors.forename: Fanny
authors.initials: F
authors.lastname: Baran-Marszak
authors.forename: Martine
authors.initials: M
authors.lastname: Raphaël
authors.forename: François
authors.initials: F
authors.lastname: Boué
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015322:Gene Rearrangement, B-Lymphocyte; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008875:Middle Aged; D012074:Remission Induction